Asset Details
Do you wish to reserve the book?
The role of day 0 and day 4 β-human chorionic gonadotropin values and initial ultrasound findings in predicting the success of methotrexate treatment in ectopic pregnancy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The role of day 0 and day 4 β-human chorionic gonadotropin values and initial ultrasound findings in predicting the success of methotrexate treatment in ectopic pregnancy
Do you wish to request the book?
The role of day 0 and day 4 β-human chorionic gonadotropin values and initial ultrasound findings in predicting the success of methotrexate treatment in ectopic pregnancy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The role of day 0 and day 4 β-human chorionic gonadotropin values and initial ultrasound findings in predicting the success of methotrexate treatment in ectopic pregnancy
2020
Overview
OBJECTIVES: To determine the role of baseline ultrasound findings and the changes between β- human chorionic gonadotropin(hCG) values on day 0 to day 4 in patients receiving single-dose methotrexate (MTX) therapy for tubal ectopic pregnancy. MATERIAL AND METHODS: One hundred fourteen patients who were hospitalized with a diagnosis of ectopic pregnancy andtreated with single-dose methotrexate were included in this retrospective study. The successful treatment group (n = 88)comprised patients in whom serum β-hCG levels were resolved with single-dose methotrexate treatment, and the failedtreatment group (n = 26) included patients who received second dose methotrexate and/or surgery. Ultrasound findings,laboratory findings, and serum β-hCG values at the time of admission and D4 and D7 β-hCG values were compared. RESULTS: The success rate of single-dose methotrexate treatment was 77.2%. In the successful treatment group, the initialβ-hCG values of the patients were lower than the unsuccessful treatment group (1479.14 ± 1253.49, 4442.88 ± 3392.58,respectively) (p = 0.0001). A decrease of more than 35% between D0-D4 increased the probability of successful treatment(p = 0.017). Although ectopic focus size and abdominal free fluid showed no significant difference between the two groups,endometrial stripe thickness was significantly higher in the unsuccessful treatment group (12.61 ± 5.79, 9.28 ± 3.53) (p = 0.002). CONCLUSIONS: In addition to the basal β-hCG value, endometrial stripe thickness of ultrasound findings should also beconsidered in determining patients with a high chance of success in single-dose MTX treatment.β-hCG changes betweenD0-D4 may be advantageous in the clinical management of ectopic pregnancy for earlier evaluation.
Publisher
Wydawnictwo Via Medica
Subject
